Role of scratch-induced cutaneous prostaglandin D2 production on atopic-like scratching behaviour in mice

Experimental Dermatology

Volumn 16, Issue 4, 2007, Pages 331-339

  Takaoka, Akiko ^a   Arai, Iwao ^a   Sugimoto, Masanori ^a   Futaki, Nobuko ^a   Sakurai, Takanobu ^a   Honma, Yusuke ^a   Nakaike, Shiro ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Atopic dermatitis; Itch; NC Ngamice; Prostaglandin D2; Scratching behaviour

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN D2; PROSTAGLANDIN SYNTHASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BAGG ALBINO MOUSE; CONTROLLED STUDY; HUMAN; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRURITUS; SCORING SYSTEM; SCRATCHING; SKIN DEFECT; SKIN INFLAMMATION;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DERMATITIS, ATOPIC; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; MICE, INBRED BALB C; PROSTAGLANDIN D2; PRURITUS; SKIN; SPECIFIC PATHOGEN-FREE ORGANISMS; STRESS, MECHANICAL;

EID: 33947178436     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00540.x     Document Type: Article

References (39)

1. Stander S, Steinhoff M, Schmelz M et al. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003: 139: 1463-1470.
2. Wahlgren C F. Itch and atopic dermatitis: An overview. J Dermatol 1999: 26: 770-779.
3. Matsuda H, Watanabe N, Geba G P et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997: 9: 461-466.
4. Takano N, Arai I, Kurachi M. Analysis of the spontaneous scratching behavior by NC/Nga mice: A possible approach to evaluate antipruritics for subjects with atopic dermatitis. Eur J Pharmacol 2003: 471: 223-228.
5. Takano N, Arai I, Hashimoto Y et al. Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice. Eur J Pharmacol 2004: 495: 159-165.
6. Klein P A, Clark R A F. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999: 135: 1522-1525.
7. Hashimoto Y, Takano N, Nakamura A et al. Scratching behaviors in NC/Nga mice with dermatitis: Involvement of histamine- induced itching. Allergol Int 2004: 53: 349-358.
8. Takano N, Arai I, Kurachi M. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice. Br J Dermatol 2006: 154: 426-430.
9. Hashimoto Y, Arai I, Takano N et al. Induction of scratching behaviour and dermatitis in various strains of mice cohabiting with NC/Nga mice with chronic dermatitis. Br J Dermatol 2006: 154: 28-33.
10. 2 biosynthesis in NC/Nga mice with atopic dermatitis. Exp Dermatol 2005: 14: 898-905.
11. Goodwin J S. Immunomodulation by eicosanoids and anti-inflammatory drugs. Curr Opin Immunol 1989: 2: 264-268.
12. Larsen G L, Henson P M. Mediators inflammation. Annu Rev Immunol 1983: 1: 335-359.
13. Marnett L J, Rowlinson S W, Goodwin D C et al. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem 1999: 274: 22903-22906.
14. Needleman P, Turk J, Jakschik B A et al. Arachidonic acid metabolism. Annu Rev Biochem 1999: 55: 69-102.
15. Ruzicka T, Printz M P. Arachidonic acid metabolism in guinea pig skin. Biochim Biophys Acta 1982: 11: 391-397.
16. Whittle B J, Moncada S, Vane J R. Comparison of the effects of prostacyclin (PGI 2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins 1978: 16: 373-388.
17. Feigen L P, Chapnick B M, Flemming J E et al. Renal vascular effects of endoperoxide analogs, prostaglandins, and arachidonic acid. Am J Physiol 1977: 233: H573-579.
18. 2. Prostaglandins 1988: 35: 277-300.
19. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ Res 1998: 82: 204-209.
20. 2 and sleep regulation. Biochim Biophys Acta 1999: 1436: 606-615.
21. 2 in the hypothermia of rats caused by bacterial lipopolysaccharide. Proc Natl Acad Sci U S A 1982: 79: 6093-6097.
22. Arai I, Takano N, Hashimoto Y et al. Prostanoid DP(1) receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 2004: 505: 229-235.
23. Sugimoto M, Arai I, Futaki N. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice. Exp Dermatol 2006: 15: 875-882.
24. 2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Eur J Pharmacol 2005: 518: 56-62.
25. Raineri R, Simsiman R C, Boutwell R K. Stimulation of the phosphorylation of mouse epidermal histones by tumor-promoting agents. Cancer Res 1978: 3: 134-139.
26. Sugimoto M, Arai I, Futaki N et al. Role of COX-1 and COX-2 on skin PGs biosynthesizing by mechanical scratching in mice. Prostaglandins Leukot Essent Fatty Acids 2006: 75: 1-8.
27. Urade Y, Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 2002: 68-69: 375-382.
28. Fogh K, Herlin T, Kragballe K. Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. J Allergy Clin Immunol 1989: 83: 450-455.
29. Ruzicka T, Simmet T, Peskar B A et al. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986: 86: 105-108.
30. 2 and its metabolites in leukocyte function. J Leukoc Biol 2007 (in press).
31. 2 receptor. J Immunol 2006: 177: 2621-2629.
32. Eguchi N, Minami T, Shirafuji N et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci U S A 1999: 96: 726-730.
33. Schmelz M. Microdialysis in itch research. In: Yosipovitch G, Greaves M W, Fleischer A B Jr, McGlone F, eds. Itch: Basic Mechanisms and Therapy. New York: Marcel Decker, Inc., 2004: 147-160.
34. Twycross R, Greaves M W, Handwerker H et. al. Itch: Scratching more than the surface. QJM 2003: 96: 7-26.
35. Leung D Y M, Boguniewicz M, Howell M D et al. New insights into atopic dermatitis. J Clin Invest 2004: 113: 651-657.
36. Schults-Larsen F, Haniffin J M. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002: 22: 1-24.
37. Dillon S R, Sprecher C, Hammond A et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004: 5: 752-760.
38. Takaoka A, Arai I, Sugimoto M et al. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Eur Pharmacol 2005: 516: 180-181.
39. Takaoka A, Arai I, Sugimoto M et al. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol 2006: 15: 161-167.